SB 547 - AS INTRODUCED
SENATE BILL 547
SPONSORS: Sen. Morgan, Dist 23; Sen. Rosenwald, Dist 13; Sen. Fuller Clark, Dist 21
COMMITTEE: Health and Human Services
This bill requires electronic prescribing for controlled drugs under certain circumstances.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Paragraph; Pharmacists and Pharmacies; Prescriptions. Amend RSA 318:47-c by inserting after paragraph II the following new paragraph:
III.(a) Notwithstanding any provision of law to the contrary, no person shall issue a prescription for a controlled drug unless the prescription is made by electronic prescription from the person issuing the prescription to a pharmacy and the electronic prescription contains the information and signature required in paragraph II, except for prescriptions issued:
(1) By veterinarians.
(2) In circumstances where electronic prescribing is not available due to temporary technological or electrical failure.
(3) By a practitioner to be dispensed by a pharmacy located outside of New Hampshire.
(4) When the prescriber and dispenser are the same entity.
(5) That include elements that are not supported by the most recently implemented version of the National Council for Prescription Drug Programs Prescriber/Pharmacist Interface SCRIPT Standard.
(6) By a practitioner for a drug that the federal Food and Drug Administration (FDA) requires the prescription to contain certain elements that are not able to be accomplished with electronic prescribing.
(7) By a practitioner allowing for the dispensing of a non-patient specific prescription pursuant to a standing order, approved protocol for drug therapy, collaborative drug management, or comprehensive medication management, in response to a public health emergency, or other circumstances where the practitioner may issue a non-patient specific prescription.
(8) By a practitioner prescribing a drug under a research protocol.
(9) By practitioners who have received a waiver or a renewal thereof for a specified period determined by the board, not to exceed one year, from the requirement to use electronic prescribing, pursuant to a process established in rules of the board, due to economic hardship, technological limitations that are not reasonably within the control of the practitioner, or other exceptional circumstance demonstrated by the practitioner.
(10) By a practitioner under circumstances where, notwithstanding the practitioner's present ability to make an electronic prescription as required by this paragraph, such practitioner reasonably determines that it would be impractical for the patient to obtain substances prescribed by electronic prescription in a timely manner, and such delay would adversely impact the patient's medical condition.
(b) A pharmacist who receives a written, oral, or faxed prescription shall not be required to verify that the prescription properly falls under one of the exceptions under subparagraph (a). Pharmacists may continue to dispense medications from otherwise valid written, oral, or faxed prescriptions that are consistent with this section.
(c) Any person who violates this paragraph shall be guilty of a civil violation for which a fine of $250 per violation, not to exceed $2,000 per calendar year, may be assessed. Notwithstanding any provision of law to the contrary, the commissioner of the department of health and human services shall enforce this paragraph pursuant to RSA 126-A:5, XXXIV.
2 New Paragraph; Commissioner of the Department of Health and Human Services; Duty Added. Amend RSA 126-A:5 by inserting after paragraph XXXIII the following new paragraph:
|Jan. 21, 2020||Senate||Hearing|
June 16, 2020: No Pending Motion; 06/16/2020 SJ 8
June 16, 2020: Vacated from Committee and Laid on Table, MA, VV; 06/16/2020 SJ 8
Jan. 21, 2020: Hearing: 01/21/2020, Room 101, LOB, 01:00 pm; SC 3
Jan. 8, 2020: To Be Introduced 01/08/2020 and Referred to Health and Human Services; SJ 1